These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 9231321)

  • 1. Sertraline-induced behavioral activation during the treatment of an adolescent with major depression.
    Guilé JM
    J Child Adolesc Psychopharmacol; 1996; 6(4):281-5. PubMed ID: 9231321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Moclobemide and sertraline in the treatment of depressive disorders: a comparative study.
    Orsel Donbak S; Turkçapar MH; Ozturk Kiliç EZ; Demirergi N; Akdemir A; Sirin A; Ozbay MH
    Acta Psychiatr Belg; 1995; 95(3):139-51. PubMed ID: 8525856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An open study of sertraline in acute and continuation treatment of depressed out-patients.
    Van Houdenhove B; Onghena P; Floris M; Janssen F; De Nayer AR; Boxus A; Iancu H
    J Int Med Res; 1997; 25(6):340-53. PubMed ID: 9427167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sertraline and speech blockage.
    Makela EH; Sullivan P; Taylor M
    J Clin Psychopharmacol; 1994 Dec; 14(6):432-3. PubMed ID: 7884029
    [No Abstract]   [Full Text] [Related]  

  • 5. Are patients who are intolerant to one SSRI intolerant to another?
    Brown WA; Harrison W
    Psychopharmacol Bull; 1992; 28(3):253-6. PubMed ID: 1480728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of comorbidity and polypharmacy on the clinical usefulness of sertraline in elderly depressed patients: an open multicentre study.
    Arranz FJ; Ros S
    J Affect Disord; 1997 Dec; 46(3):285-91. PubMed ID: 9547126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Double-blind comparison of bupropion sustained release and sertraline in depressed outpatients.
    Kavoussi RJ; Segraves RT; Hughes AR; Ascher JA; Johnston JA
    J Clin Psychiatry; 1997 Dec; 58(12):532-7. PubMed ID: 9448656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sertraline safety and efficacy in major depression: a double-blind fixed-dose comparison with placebo.
    Fabre LF; Abuzzahab FS; Amin M; Claghorn JL; Mendels J; Petrie WM; Dubé S; Small JG
    Biol Psychiatry; 1995 Nov; 38(9):592-602. PubMed ID: 8573661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controlling acute episodes of depression.
    Lapierre YD
    Int Clin Psychopharmacol; 1991 Dec; 6 Suppl 2():23-35. PubMed ID: 1806627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sertraline in the prevention of depression.
    Doogan DP; Caillard V
    Br J Psychiatry; 1992 Feb; 160():217-22. PubMed ID: 1540762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of sertraline in a patient with recurrent hyponatremia.
    Catalano G; Kanfer SN; Catalano MC; Alberts VA
    Gen Hosp Psychiatry; 1996 Jul; 18(4):278-83. PubMed ID: 8832263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Sertraline in the treatment of mixed anxiety and depression disorder].
    Carrasco JL; Díaz-Marsá M; Sáiz J
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1997; 25(3):141-5. PubMed ID: 9381956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An open study of the effects of sertraline on adolescent major depression.
    McConville BJ; Minnery KL; Sorter MT; West SA; Friedman LM; Christian K
    J Child Adolesc Psychopharmacol; 1996; 6(1):41-51. PubMed ID: 9231298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Priapism with sertraline and lithium.
    Mendelson WB; Franko T
    J Clin Psychopharmacol; 1994 Dec; 14(6):434-5. PubMed ID: 7884031
    [No Abstract]   [Full Text] [Related]  

  • 15. Patient prescribed sertraline charged with driving under the influence.
    Lock J
    J Clin Psychopharmacol; 1997 Feb; 17(1):61. PubMed ID: 9004065
    [No Abstract]   [Full Text] [Related]  

  • 16. Reemergence of sexual dysfunction in patients with major depressive disorder: double-blind comparison of nefazodone and sertraline.
    Ferguson JM; Shrivastava RK; Stahl SM; Hartford JT; Borian F; Ieni J; McQuade RD; Jody D
    J Clin Psychiatry; 2001 Jan; 62(1):24-9. PubMed ID: 11235924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of different relapse criteria on the assessment of long-term efficacy of sertraline.
    Montgomery SA; Doogan DP; Burnside R
    Int Clin Psychopharmacol; 1991 Dec; 6 Suppl 2():37-46. PubMed ID: 1806629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of sertraline on mood and immune status in patients with major depression and HIV illness: an open trial.
    Rabkin JG; Wagner G; Rabkin R
    J Clin Psychiatry; 1994 Oct; 55(10):433-9. PubMed ID: 7961520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical implications of the pharmacology of sertraline.
    Warrington SJ
    Int Clin Psychopharmacol; 1991 Dec; 6 Suppl 2():11-21. PubMed ID: 1806626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case of sertraline-induced stuttering.
    Christensen RC; Byerly MJ; McElroy RA
    J Clin Psychopharmacol; 1996 Feb; 16(1):92-3. PubMed ID: 8834434
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.